1 |
Gelband H, Sankaranarayanan R, Gauvreau CL, et al (2015). Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middleincome countries: key messages from Disease Control Priorities. Lancet, 387, 2133-44.
|
2 |
GHDx. 2015. Global Burden of Disease Study 2013 (GBD 2013) Data Citations, Iran [Online]. Institute for Health Metrics and Evaluation.
|
3 |
GLOBOCAN. 2013a. Data sources and Methods [Online]. France, Lyon: IARC.
|
4 |
GLOBOCAN. 2013b. Data Sources and Methods, IR Iran [Online]. France, Lyon.
|
5 |
GLOBOCAN. 2013c. Incidence/ Mortality Rates: Cancer by population [Online]. France, Lyon.
|
6 |
Haidari M, Nikbakht MR, Pasdar Y, et al (2012). Trend analysis of gastric cancer incidence in Iran and its six geographical areas during 2000-2005. Asian Pac J Cancer Prev, 13, 3335-41.
DOI
|
7 |
Kelishadi R, Alikhani S, Delavari A, et al (2008). Obesity and associated lifestyle behaviours in Iran: findings from the first national non-communicable disease risk factor surveillance survey. Public Health Nutr, 11, 246-51.
|
8 |
Khosravi A, Taylor R, Naghavi M, et al (2007a). Differential mortality in Iran. Popul Health Metr, 5, 1.
DOI
|
9 |
Khosravi A, Taylor R, Naghavi M, et al (2007b). Mortality in the islamic republic of Iran, 1964-2004. Bull World Health Organ, 85, 607-14.
DOI
|
10 |
Lankarani KB, Khosravizadegan Z, Rezaianzadeh A, et al (2013). Data coverage of a cancer registry in southern Iran before and after implementation of a population-based reporting system: a 10-year trend study. BMC Health Services Res, 13, 169.
DOI
|
11 |
Maryam M, Ali-Akbar H, Eshagh D, et al (2015). Completeness and underestimation of cancer mortality rate in Iran: a report from Fars province in Southern Iran. Arch Iran Med, 18, 160-6..
|
12 |
Somi MH, Farhang S, Mirinezhad SK, et al (2008). Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 9, 327-30.
|
13 |
Babaei M, Jaafarzadeh H, Sadjadi A, et al (2009). Cancer incidence and mortality in Ardabil: Report of an ongoing population-based cancer registry in Iran, 2004-2006. Iran J Public Health, 38, 35-45.
|
14 |
Babaei M, Mousavi S, Malek M, et al (2005). Cancer occurrence in Semnan Province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 6, 159-64.
|
15 |
Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8.
DOI
|
16 |
Safavi A, Azizi F, Jafari R, et al (2015). Thyroid cancer epidemiology in Iran: a time trend study. Asian Pac J Cancer Prev, 17, 407-12.
|
17 |
Sajdiadi A ZM, Moghadam SD. ( 2007). The first populationbased cancer survey in Kerman Province of Iran. Iranian J Public Health, 36, 26 - 34.
|
18 |
Vahedi M, Pourhoseingholi MA, Baghestani A, et al (2013). Bayesian analysis of lung cancer mortality in the presence of misclassification. Iran J Cancer Prev, 6, 1-5.
|
19 |
Zahir ST, Mirtalebi M (2012). Survival of patients with lung cancer, Yazd, Iran. Asian Pac J Cancer Prev, 13, 4387-91.
DOI
|
20 |
Zendehdel K, Sedighi Z, Hassanloo J, et al (2011). Audit of a nationwide pathology-based cancer registry in Iran. Basic Clin Cancer Res, 3, 7-13.
|
21 |
Fitzmaurice C, Dicker D, Pain A, et al (2015). The global burden of cancer 2013, eAppendix. JAMA oncol, 1, 505-27.
DOI
|
22 |
Farahmand M, Khademolhosseini F, Medhati M, et al (2009). Trend of bladder cancer in Fars province, southern Iran, 2002-2006. Iran Red Crescent Med J, 11, 470-2.
|
23 |
Farzadfar F, Danaei G, Namdaritabar H, et al (2011). National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr, 9, 1.
DOI
|
24 |
Fazeli Z, Pourhoseingholi MA, Vahedi M, et al (2013). Leukemia cancer mortality trend in Iran, from 1995 to 2004. Iran J Cancer Prev, 6, 170.
|
25 |
Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
|
26 |
Mathers CD, Ma Fat D, Inoue M, et al (2005). Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ, 83, 171-7.
|
27 |
Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, et al (2009). Cancer incidence in Tehran metropolis: the first report from the Tehran Population-based Cancer Registry, 1998-2001. Arch Iran Med, 12, 15-23.
|
28 |
Mohammad K, Nourbala A, Madjdzadeh R, et al (2001). Trend of smoking prevalence in Iran from 1991 to 1999 based on two national health survey. Hakim, 3, 290-4.
|
29 |
Noroozian M (2012). The Elderly population in Iran: An ever growing concern in the health system. Iran J Psychiatry Behav Sci, 6, 1-6.
|
30 |
Parkin DM, Bray F (2009). Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer, 45, 756-64.
DOI
|
31 |
Pourhoseingholi M, Faghihzadeh S, Hajizadeh E, et al (2011). Trend analysis of gastric cancer and colorectal cancer mortality in Iran, 1995-2003. Iran J Cancer Prev, 4, 38-43.
|
32 |
Pourmalek F, Abolhassani F, Naghavi M, et al (2009). Direct estimation of life expectancy in the Islamic Republic of Iran in 2003. East Mediterr Health J, 15, 76-84.
DOI
|
33 |
Rahimi F, Heidari M (2012). Time trend analysis of stomach cancer incidence in the west of Iran. J Health Development, 1, 11 (In Farsi).
|
34 |
Roshandel G, Sadjadi A, Aarabi M, et al (2012). Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med, 15, 196-200.
|